Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth

Title: Targeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growth
Authors: He,Aina; Tian,Songhai; Kopper,Oded; Horan,Daniel J.; Chen,Peng; Bronson,Roderick T.; Sheng,Ren; Wu,Hao; Sui,Lufei; Zhou,Kun; Tao,Liang; Wu,Quan; Huang,Yujing; Shen,Zan; Han,Sen; Chen,Xueqing; Chen,Hong; He,Xi; Robling,Alexander G.; Jin,Rongsheng; Clevers, Hans; Xiang,Dongxi; Li,Zhe; Dong,Min; CMM; Cancer; Hubrecht Institute with UMC
Publication Year: 2023
Subject Terms: General Neuroscience; General Biochemistry,Genetics and Molecular Biology; General Immunology and Microbiology; General Agricultural and Biological Sciences
Description: Wnt signaling pathways are transmitted via 10 homologous frizzled receptors (FZD1-10) in humans. Reagents broadly inhibiting Wnt signaling pathways reduce growth and metastasis of many tumors, but their therapeutic development has been hampered by the side effect. Inhibitors targeting specific Wnt-FZD pair(s) enriched in cancer cells may reduce side effect, but the therapeutic effect of narrow-spectrum Wnt-FZD inhibitors remains to be established in vivo. Here, we developed a fragment of C. difficile toxin B (TcdBFBD), which recognizes and inhibits a subclass of FZDs, FZD1/2/7, and examined whether targeting this FZD subgroup may offer therapeutic benefits for treating breast cancer models in mice. Utilizing 2 basal-like and 1 luminal-like breast cancer models, we found that TcdBFBD reduces tumor-initiating cells and attenuates growth of basal-like mammary tumor organoids and xenografted tumors, without damaging Wnt-sensitive tissues such as bones in vivo. Furthermore, FZD1/2/7–positive cells are enriched in chemotherapy-resistant cells in both basal-like and luminal mammary tumors treated with cisplatin, and TcdBFBD synergizes strongly with cisplatin in inhibiting both tumor types. These data demonstrate the therapeutic value of narrow-spectrum Wnt signaling inhibitor in treating breast cancers.
Document Type: article in journal/newspaper
File Description: text/plain
Language: English
ISSN: 1544-9173
Relation: https://dspace.library.uu.nl/handle/1874/451214
Availability: https://dspace.library.uu.nl/handle/1874/451214
Rights: info:eu-repo/semantics/OpenAccess
Accession Number: edsbas.54E7A541
Database: BASE